AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2017
Jun 28, 2017
31721_dirs_2017-06-28_1957eb67-d483-4d25-a4f4-7759d9e2b1cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-06-26
Reporting Person: INGRAM DOUGLAS S (Director, President & CEO)
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4